---
title: "Projet"
author: "Lancelot RAVIER, Jade BORDET, Sara MEKKAOUI, Manal BELOUARDA"
format:
  revealjs:
    css: assets/styles.css
    resources: images
    header-includes: |
      <script src="assets/custom.js" type="application/javascript"></script>
      <style> .no-split {page-break-inside: avoid;} </style>

      
---
## Outline {transition="fade" transition-speed="slow"}
- Presentation of the institute
- Goals of the project
    - Benefits and stakeholders



## The institute


![](images/labo.png){.r-stretch fig-align="center"}

* Supervision: Conducted by the "Epigenetic Regulations" team at the Institute for Advanced Biosciences in Grenoble.
* Expertise: Focus on epigenetic mechanisms, particularly their role in diseases like cancer.
* Impact: Significant contributions to personalized medicine through advanced bioinformatics and multi-omics analyses.



## Project Goal and stakeholders
![](images/0.png){.r-stretch fig-align="center"}



## What is Epigenetics? {.smaller transition="slide" transition-speed="slow"}

<img src="images/1.png" style="float: right">

**Gene Expression Without DNA Changes**

- Study of how genes are turned on or off without altering the DNA sequence.


---

## The diversity of cell types and functions in complex organisms {.smaller transition="slide" transition-speed="slow"}

<img src="images/2.png" style="float: right">

**Examples of Epigenetic Regulation**

- Differences between brain and skin cells despite identical DNA.  

## How epigenetics works {.smaller transition="slide" transition-speed="slow"}

<img src="images/3.png" style="float: right">

tumor, end ??
é## DNA Methylation


## Influence of cancer in genes expression

![](images/epi_cancer.jpg){.r-stretch fig-align="center"}

## Influence of cancer in genes expression
![](images/epi_cancer_2.jpg){.r-stretch fig-align="center"}


## Gene Expression Classifier (GEC)




## Dataset description
- Types of available files : Gene expression levels, Bioclinical annotations of samples, GEC scores

![](images/1-dataset_secription.JPG){.r-stretch fig-align="center"}

##  Filtering Data
- Identify colon cancer-specific samples (T-Colon group).
- The initial files are not cleaned.

![](images/2-filtering_data.JPG){.r-stretch fig-align="center"}

##  Filtering Data
- Identify colon cancer-specific samples (T-Colon group).
- The initial files are not cleaned.

![](images/3-filteringdata.JPG){.r-stretch fig-align="center"}

## Survival analysis GEC 4 and 3
- Data Preparation:
- Extract data from two sources:GEC annotation file, Clinical annotation file
- Survival data limit: Set at 120 months (10 years)
- Goal: Develop a simplified prognostic test using the GEC signature for hospital use.
- A reduced 3-GEC signature is clinically feasible.
![](images/survival_curve_3GEC_GSE39582.png){.absolute right=0 width="500" height="5"}

## Survival analysis GEC 4 and 3
![](images/survival_curve_TCGA-COAD-FPKM.png){.absolute left=0 width="500" height="500"}

![](images/survival_curve_3GEC_TCGA-COAD-FPKM.png){.absolute right=0 width="500" height="500"}

## Survival analysis GEC 4 and 3
![](images/survival_curve_GSE17536.png){.absolute left=0 width="500" height="500"}

![](images/survival_curve_3GEC_GSE17536.png){.absolute right=0 width="500" height="500"}

## Survival analysis GEC 4 and 3
![](images/survival_curve_GSE39582.png){.absolute left=0 width="500" height="500"}

![](images/survival_curve_3GEC_GSE39582.png){.absolute right=0 width="500" height="500"}

## Genes mutation analyses

## Mutation data {.smaller transition="slide" transition-speed="slow"}
* Objective: Identify microsatellite instability (MSI) through mutation analysis.
<img src="images/donner_mutation.png" style="float: right">



## Distribution MSI/MSS {.smaller transition="slide" transition-speed="slow"}

<img src="images/distribution_msi_mss.png" style="float: right">

**Identify MSI samples**

## Results of cox test {.smaller transition="slide" transition-speed="slow"}

**HR and p-value**
* MSI Hazard Ratio (HR): ~0.80 (20% lower risk of death for MSI patients).
* Result not statistically significant, requiring larger sample sizes for confirmation.

![](images/resultats_test_cox_mutation.png)

## Survival curves for MSI/MSS {.smaller transition="slide" transition-speed="slow"}

<img src="images/curves_msi_mss.png" style="float: center">






## Methylation of MLH1 gene {.smaller transition="slide" transition-speed="slow"}
![](images/meth_0.png)


## Methylation dataset {.smaller transition="slide" transition-speed="slow"}
![](images/meth_data_1.png){.r-stretch fig-align="center"}


## MLH1 Expression dataset {.smaller transition="slide" transition-speed="slow"}
![](images/expression.png){.r-stretch fig-align="center"}


## Cleaned dataset {.smaller transition="slide" transition-speed="slow"}

![](images/final_data_meth.png){.r-stretch fig-align="center"}

## Results : {.smaller transition="slide" transition-speed="slow"}

- Significant high negative correlation, decreasing regression line
- MSI/MSS Clusters identification

![](images/meth_graph.png){.r-stretch fig-align="center"}

## CNA Analysis (MSI / MSS / unknown)


## MSI/MSS status for all tumor samples{.smaller}
- The promoter region of the MLH1 gene is methylated.
- A mutation occurs in one of the MLH1, MSH2, MSH6, or PMS2 genes.
- An entire DNA region containing one of these genes is lost(CNA)

![](images/MSIMSS.JPG){.r-stretch fig-align="center"}

## Team Collaboration

![](images/trello.png)


## Conclusion


















## Epigenetics {.smaller transition="slide" transition-speed="slow"}

<img src="images/1.png" style="float: right">


**20th century - genetics**

Genetics (from the Greek “to give birth”) is the science that studies heredity and genes.

1909 - genes and heredity discovery
1953 - DNA double helix discovery
1977 - sequencing the first DNA fragments
2003 - complete sequencing of the human genome

**$21^{th}$ century - genetics**

Epigenetics (from the Greek epi: above) studies the molecular mechanisms that modify gene expression as a function of the environment.



## Epigenetics regulation {.smaller transition="convex" transition-speed="slow"}
![](images/2.png){.r-stretch fig-align="center"}



## Epigenetics regulation {.smaller transition="concave" transition-speed="slow"}
![](images/3.png){.r-stretch fig-align="center"}



## Epigenetics regulation {.smaller transition="zoom" transition-speed="slow"}
![](images/4.png){.r-stretch fig-align="center"}



## Aberrant (ectopic) activations of genes in cancer
::: {.r-stack}
![](images/5_1.png){.absolute left=0 .fragment}

![](images/5_2.png){.absolute right=0 .fragment width="300" height="450"}
:::



## Aberrant (ectopic) activations of genes in cancer
![](images/6.png){.r-stretch fig-align="center"}



